论文部分内容阅读
肾动脉狭窄与进行性缺血性肾衰竭和高血压相关的心血管疾病的发病率和死亡率有着密切关系。对于此类患者的治疗现在并无确定方法。现比较各种治疗的临床研究结果。内科药物治疗是各种治疗的基础,而且仍有进一步研究的空间。目前的资料显示腔内治疗相比外科和单纯内科治疗有一定的优势,但一些特殊的病例,外科治疗仍然是很好的选择。介入治疗中一些新技术,如肾动脉远端保护装置及药物涂层支架在临床应用已有尝试,但仍处于探索阶段。目前仍需大样本多中心随机对照试验来进一步明确证明介入治疗的作用。
Renal artery stenosis and progressive ischemic renal failure and hypertension-related cardiovascular disease incidence and mortality are closely related. There is no definitive way to treat such patients. Now compare the clinical treatment of various treatment results. Internal medicine treatment is the basis of various treatments, and there is still room for further research. The current data show that endovascular treatment has some advantages over surgery and simple medical treatment, but some special cases and surgical treatment are still good choices. Some new interventional techniques, such as distal renal protection devices and drug-coated stents, have been tried in clinical practice but are still in the exploratory stage. There is still a large sample of multicenter randomized controlled trials to further clarify the role of interventional therapy.